These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 2879611

  • 1. Regulation of the concentration of dynorphin A1-8 in the striatonigral pathway by the dopaminergic system.
    Li S, Sivam SP, Hong JS.
    Brain Res; 1986 Nov 29; 398(2):390-2. PubMed ID: 2879611
    [Abstract] [Full Text] [Related]

  • 2. Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum.
    Li SJ, Jiang HK, Stachowiak MS, Hudson PM, Owyang V, Nanry K, Tilson HA, Hong JS.
    Brain Res Mol Brain Res; 1990 Aug 29; 8(3):219-25. PubMed ID: 1977070
    [Abstract] [Full Text] [Related]

  • 3. Regulation of the metabolism of striatal dynorphin by the dopaminergic system.
    Li SJ, Sivam SP, McGinty JF, Jiang HK, Douglass J, Calavetta L, Hong JS.
    J Pharmacol Exp Ther; 1988 Jul 29; 246(1):403-8. PubMed ID: 2899169
    [Abstract] [Full Text] [Related]

  • 4. Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway.
    Li SJ, Sivam SP, McGinty JF, Huang YS, Hong JS.
    J Pharmacol Exp Ther; 1987 Nov 29; 243(2):792-8. PubMed ID: 2445959
    [Abstract] [Full Text] [Related]

  • 5. Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra.
    Quirion R, Gaudreau P, Martel JC, St-Pierre S, Zamir N.
    Brain Res; 1985 Apr 08; 331(2):358-62. PubMed ID: 2859094
    [Abstract] [Full Text] [Related]

  • 6. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
    Jiang HK, McGinty JF, Hong JS.
    Brain Res; 1990 Jan 15; 507(1):57-64. PubMed ID: 1967976
    [Abstract] [Full Text] [Related]

  • 7. Regulation of striatonigral prodynorphin peptides by dopaminergic agents.
    Trujillo KA, Day R, Akil H.
    Brain Res; 1990 Jun 04; 518(1-2):244-56. PubMed ID: 1975215
    [Abstract] [Full Text] [Related]

  • 8. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
    Reid MS, Herrera-Marschitz M, Hökfelt T, Lindefors N, Persson H, Ungerstedt U.
    Exp Brain Res; 1990 Jun 04; 82(2):293-303. PubMed ID: 1704847
    [Abstract] [Full Text] [Related]

  • 9. A 35 kDa Fos-related antigen is co-localized with substance P and dynorphin in striatal neurons.
    Zhang WQ, Pennypacker KR, Ye H, Merchenthaler IJ, Grimes L, Iadarola MJ, Hong JS.
    Brain Res; 1992 Apr 17; 577(2):312-7. PubMed ID: 1376635
    [Abstract] [Full Text] [Related]

  • 10. Lithium increases dynorphin A(1-8) and prodynorphin mRNA levels in the basal ganglia of rats.
    Sivam SP, Takeuchi K, Li S, Douglass J, Civelli O, Calvetta L, Herbert E, McGinty JF, Hong JS.
    Brain Res; 1988 Apr 17; 427(2):155-63. PubMed ID: 2898269
    [Abstract] [Full Text] [Related]

  • 11. Dopamine characteristics in different rat genotypes: the relation to absence epilepsy.
    de Bruin NM, van Luijtelaar EL, Jansen SJ, Cools AR, Ellenbroek BA.
    Neurosci Res; 2000 Oct 17; 38(2):165-73. PubMed ID: 11000443
    [Abstract] [Full Text] [Related]

  • 12. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.
    Sivam SP.
    J Pharmacol Exp Ther; 1989 Sep 17; 250(3):818-24. PubMed ID: 2476548
    [Abstract] [Full Text] [Related]

  • 13. Ganglioside interactions with the dopaminergic system of rats.
    Tilson HA, Harry GJ, Nanry K, Hudson PM, Hong JS.
    J Neurosci Res; 1988 Sep 17; 19(1):88-93. PubMed ID: 3125345
    [Abstract] [Full Text] [Related]

  • 14. Differential subsensitivity of dopaminergic and neostriatal neurons to apomorphine with long-term treatment.
    Rebec GV, Lee EH.
    Brain Res; 1982 Oct 28; 250(1):188-92. PubMed ID: 7139316
    [Abstract] [Full Text] [Related]

  • 15. Response of striatonigral substance P systems to a dopamine receptor agonist and antagonist.
    Hanson G, Alphs L, Pradhan S, Lovenberg W.
    Neuropharmacology; 1981 Jun 28; 20(6):541-8. PubMed ID: 6165922
    [No Abstract] [Full Text] [Related]

  • 16. Steady state levels of pro-dynorphin-related end products in the striatum and substantia nigra of the adult rhesus monkey.
    Dores RM, Akil H.
    Peptides; 1985 Jun 28; 6 Suppl 2():143-8. PubMed ID: 2867528
    [Abstract] [Full Text] [Related]

  • 17. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
    Reid MS, O'Connor WT, Herrera-Marschitz M, Ungerstedt U.
    Brain Res; 1990 Jun 11; 519(1-2):255-60. PubMed ID: 1975763
    [Abstract] [Full Text] [Related]

  • 18. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 11; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 19. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A, Parenti M, Cattabeni F, Maggi A, De Angelis L, Monduzzi M, Racagni G.
    Adv Biochem Psychopharmacol; 1978 Mar 11; 19():363-71. PubMed ID: 696464
    [No Abstract] [Full Text] [Related]

  • 20. Cholecystokinin system in striatal-nigral neuronal networks: infusion of quinolinic acid into rat striatum.
    Takita M, Kato T.
    Neuropeptides; 1989 Jan 11; 13(1):71-4. PubMed ID: 2922108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.